Israel Pharmaceuticals & Healthcare Report

Bharatbook.com has this special report, which sources information of The Israel Pharmaceuticals
and Healthcare Report has been researched at source and features the latest available data and
forecasts to end-2015 covering drugs.

The prescription, OTC and generics markets, and foreign trade; company rankings and
competitive landscapes including multinational and national drugs companies; and analysis of
latest industry news, trends and regulatory developments.

Business Monitor International’s Israel Pharmaceuticals and Healthcare Report provides industry
professionals, market investors and corporate and financial services analysts with independent
forecasts and competitive intelligence on the Israeli pharmaceutical & healthcare industry.

Key Benefits of Report

* Benchmark BMI’s Independent 5-year Pharmaceutical and Healthcare Industry Forecasts on

Israel to test other views – a key input for successful budgeting and strategic business planning in
the Israeli pharmaceutical and healthcare market.
* Target Business Opportunities & Risks in the Israeli Pharmaceutical and Healthcare Sector
through our reviews of latest industry trends, regulatory changes and major deals, projects and
investments in Israel.
* Exploit The Latest Competitive Israeli Pharmaceutical and Healthcare Intelligence & Company
SWOTS on your competitors and peers through company rankings by sales, market share and
ownership structure – includes multi-national and national companies in Israel.

Coverage

Executive Summary & Industry SWOT

An at-a-glance perspective on latest regulatory developments, key forecast indicators and major
corporate developments, covering the prescription, OTC and generics markets. The SWOT
outlines strategic factors which affect BMI’s forecast analysis, and taken together with BMI’s
Economic and Business Environment SWOTS, give a complete overview of market climate.

Market Summary

Outline of market characteristics, growth factors, leading therapeutic segments and a

competitivness of the market.

Regulatory Regime

Guide to and analysis of country intellectual property developments and pricing & reimbursement
issues, which constitute the regulatory make-up of the market.

Industry Developments

Focus on government healthcare reforms, epidemiological trends, company M&As, product

launches, market entries, FDI activity, R&D and patent legislation.

BMI 5-Year Industry Forecast

5-Year Forecasts to end-2015 for all key industry indicators (see list below), supported by explicit
assumptions, plus analysis of key downside risks to the main forecast, including:

* Drug market expenditure (US$bn); drug expenditure per capita (US$); as % of gdp
* Prescription drug market (US$bn)/as % of total market; sales by alimentary tract/metabolism;
antibiotics, cardiovascular, central nervous system, oncology, musculoskeletal and respiratory
system
* OTC market (US$bn)/as % of total market (sales by analgesic, cough and cold, digestives, skin
treatments, vitamins and minerals)
* Generics market (US$bn)/ as % of total market
* Health expenditure (US$bn, % of gdp and per capita); public sector health expenditure as % of
total; number of hospitals; beds, hospital admissions, doctors, births and deaths per 000
population

Forecasts based on bespoke BMI economic modelling, using historical data sets of
macroeconomic and industry variables to derive rigorous statistical relationships, anchored in
advanced linear regression techniques.

BMI 5-Year Macroeconomic Forecasts

BMI forecasts for all headline macroeconomic indicators, including:

Nominal and real GDP, % real GDP growth, % private consumption growth, % industrial output
growth, % consumer price index, % GDP price deflator, exports, imports, trade balance, current
account balance, foreign direct investment, exchange rate against US$, government expenditure
and external debt.

Competitive Landscape & Profiles

Intelligence on the market position of major MNC power houses and indigenous companies. BMI
profiles key research-based companies. Company SWOTS are provided for all key strategic
players, complete with a company activity overview, its leading products and analysis of business
opportunities.

For more information kindly visit :

http://www.bharatbook.com/detail.asp?id=18740&rt=Israel-Pharmaceuticals-Healthcare-
Report.html

Related Reports

India Pharmaceuticals & Healthcare Report

http://www.bharatbook.com/detail.asp?id=6835&rt=India-Pharmaceuticals-Healthcare-
Report.html

Australia Pharmaceuticals & Healthcare Report

http://www.bharatbook.com/detail.asp?id=18701&rt=Australia-Pharmaceuticals-
Healthcare-Report.html

Or

Contact us at :

Bharat Book Bureau

Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/BharatBook
Please visit our blog at http://bharatresearch.wordpress.com

Healthcare, Market Leaders, Medical, Report, Research, SWOT analysis